🔍
Rapid Induction of Cancer Cell Death by Synergistic Treatment of Tetra-O-methyl Nordihydroguaiaretic Acid (M4N) with either Rottlerin or Ly294002
Case ID:
C10281
Report of Invention:
1/3/2008
Web Published:
10/7/2014
Technical Details:
M4N is an anti-cancer drug candidate, which is currently under the first phase of clinical trials. Although M4N can reduce tumor cell growth; it fails to induce quick tumor cell death. JHU scientists showed that the combination treatment of M4N with either two specific kinase inhibitors overcomes this problem. In vivo study demonstrated that the combination treatment reduced tumor metastasis and extended life expectancy of tumor-bearing mice significantly. This combination treatment can be a very important to improve the efficacy of M4N as an anti-cancer drug.
Looking for Partners:
This technology can be used to produce liquid containing M4N with an optimal amount ratio of M4N to either two specific kinase inhibitors. This will allow physicians to prescribe the optimal dosages of this combination treatment to patients.
Patent Status: Issued Patents US 9149526; EP 2240168
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Supression of Cancer Growth and Metastasis Using Nordihydroguaiaretic Acid Derivatives with Metabolic Modulators
PCT: Patent Cooperation Treaty
United States
12/812,196
9,149,526
9/30/2010
10/6/2015
1/8/2029
Granted
Direct Link:
https://jhu.technologypublisher.com/technology/16624
Inventors:
Category(s):
Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum